| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 |
| filingDate |
1997-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34c683ccfc4f24b0ba479660a4858d92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13dd855c6cd510a3943fb44610135a2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b3ea5e05bdc6275ae03e0a991afbb02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cdeed3dfe7d0cc7af8718b1da2369fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c5da0f3859de8fb68131b6bc1b33a01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_210af18fa5ba53c0b9e7310d8ff74676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ba9ce9ff5413d4896a6b5519bdd035a |
| publicationDate |
2004-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0822260-B1 |
| titleOfInvention |
Substance fa-70d, process for producing the same, and uses thereof |
| abstract |
Substance FA-70D which has the following formula (1) or its salt, a method for its production, a pharmaceutical composition comprising the compound as an active ingredient, a method of treating osteoporosis which comprises administering the compound, use of the compound as a drug, and a microorganism capable of producing Substance FA-70D. <CHEM> This compound has specific inhibitory activity against cathepsin series proteases and is of value as a therapeutic drug for various diseases with which these enzymes are associated, particularly osteoporosis. |
| priorityDate |
1996-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |